Hostname: page-component-848d4c4894-tn8tq Total loading time: 0 Render date: 2024-06-16T09:05:20.932Z Has data issue: false hasContentIssue false
  • English
  • Français

Biochemical Markers of Excitability in Human Neocortex

Published online by Cambridge University Press:  18 September 2015

A.L. Sherwin ,
O. Vernet ,
F. Dubeau  and
A. Olivier
A.L. Sherwin*
Affiliation:
Montreal Neurological Institute and the Department of Neurology and Neurosurgery, McGill University, Montreal
O. Vernet
Affiliation:
Montreal Neurological Institute and the Department of Neurology and Neurosurgery, McGill University, Montreal
F. Dubeau
Affiliation:
Montreal Neurological Institute and the Department of Neurology and Neurosurgery, McGill University, Montreal
A. Olivier
Affiliation:
Montreal Neurological Institute and the Department of Neurology and Neurosurgery, McGill University, Montreal
*
Montreal Neurological Institute, 3801 University Street, Montreal, Quebec, Canada H3A 2B4
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

We measured biochemical markers of excitability in brain excised for neurosurgical therapy of epilepsy. Intraoperative electrocorticography was used to identify and compare samples from regions of persistent interictal spike discharges and areas of the cerebral convexity which were free of interictal piking. We found that interictal spiking was associated with elevated tissue levels of the excitatory amino acids glutamic acid (26%, p < 0.001) and aspartic acid (25%, p < 0.05). There was also a significant increase in the activity of the enzymes glutamic acid dehydrogenase (20%, p < 0.01) and aspartate acid aminotransferase (18%, p < 0.01) which are involved in their formation. There was no change in the levels of the inhibitory neurotransmitters GABA or taurine. We also found a significant increase in the activity of tyrosine hydroxylase (52%, p < 0.001), the rate controlling enzyme in catecholamine biosynthesis. There was a reduction in the density (Bmax) of cortical alpha-1 adrenoceptors (26%, p < 0.01) and a concommitant diminution of receptor coupled phosphatidylinositide metabolism (21%, p < 0.01). This blunting of inhibitory noradrenergic transmembrane signaling may contribute to a relative imbalance between excitatory and inhibitory mechanisms in epileptogenic neocortex.

Type
Research Article
Information
Canadian Journal of Neurological Sciences , Volume 18 , Issue S4 , November 1991 , pp. 640 - 644
Copyright
Copyright © Canadian Neurological Sciences Federation 1991

References

REFERENCES

1.Dichter, MA, Ayala, GF. Cellular mechanisms of epilepsy: A status report. Science 1987; 237: 157–164.CrossRefGoogle ScholarPubMed
2.Prince, A. Physiological mechanisms of focal epileptogenesis. Epilepsia 1985; 26(Suppl 1): S3–S14.CrossRefGoogle ScholarPubMed
3.Engel, J Jr. New concepts of the epileptic focus. In: Wieser, HG, Speckmann, EG, Engel, J Jr, eds. The Epileptic Focus. London: John Libbey Eurotext, 1987.Google Scholar
4.Robitaille, Y. Neuropathological findings in epileptic foci. In: Wieser, HG, Speckmann, EG, Engel, J Jr, eds. The Epileptic Focus. London: John Libbey Eurotext 1987; 95–112.Google Scholar
5.Quesney, LF, Gloor, P. Localization of epileptic foci. In: Gotman, J, Ives, JR, Gloor, P, eds. Long Term Monitoring in Epilepsy. Electroenceph Clin Neurophysiol, Suppl 37. Amsterdam Elsevier 1985; 165–200.Google Scholar
6.Gotman, J, Marciani, MG. Electroencephalographic spiking activity, drug levels, and seizure occurrence in epileptic patients. Ann Neurol 1985; 17: 597–603.CrossRefGoogle ScholarPubMed
7.Olivier, A. Cortical resections. In: Engel, J Jr, ed. Surgical Treatment of the Epilepsies. New York: Raven Press 1987; 405–424.Google Scholar
8.Gloor, P. Contributions of electroencephalography and electrocor-ticography to the neurosurgical treatment of epilepsies. In: Purpura, DP, Penry, JK, Walters, RD, eds. Advances In Neurology, vol 8: Neurosurgical Management of the Epilepsies. New York: Raven Press 1975; 59–105.Google Scholar
9.Brière, R, Sherwin, AL, Robitaille, Y, et al. Alpha-1 adrenoceptors are decreased in human epileptic foci. Ann Neurol 1986; 19: 26–30.CrossRefGoogle ScholarPubMed
10.Sherwin, AL, Robitaille, Y, Quesney, F, et al. Excitatory amino acids are elevated in human epileptic cerebral cortex. Neurology 1988; 38: 920–923.CrossRefGoogle ScholarPubMed
11.Sherwin, AL. Guide to neurochemical analysis of surgical speci-mens of human brain. Epilepsy Res 1988; 2: 281–288.CrossRefGoogle Scholar
12.Chapman, AG. Amino acid abnormalities in plasma, CSF and brain in epilepsy. In: Pedley, TA, Meldrum, BS, eds. Recent Advances in Epilepsy. Vol 4. New York: Churchill Livingston 1988; 46–62.Google Scholar
13.Delgado-Esqueta, AV, Ward, AA Jr, Woodbury, DM, et al. New wave of research in the epilepsies. In: Delgado-Esqueta, AV, Ward, AA Jr, Woodbury, DM, Porter, RJ, eds. Basic Mechanisms of the Epilepsies. New York: Raven Press 1986; 1011–1032.Google Scholar
14.Sherwin, AL, van Gelder, NM. Amino acid and catecholamine markers of metabolic abnormalities in human focal epilepsy. In: Delgado-Esqueta, AV, Ward, AA Jr, Woodbury, DM, Porter, RJ, eds. Basic Mechanisms of the Epilepsies. New York: Raven Press 1986; 1011–1032.Google Scholar
15.Dubeau, F, Sherwin, AL. Adrenergic mediated phosphatidylinositol metabolism is modulated by epileptic discharges in human neocortex. Brain Res 1989; 481: 200–203.CrossRefGoogle ScholarPubMed
16.Meldrum, B. Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters. Clin Sci 1985; 68: 133–122.CrossRefGoogle ScholarPubMed
17.Van Gelder, NM. Contributions of basic neurochemistry towards a novel concept of epilepsy. Neurochem Res 1987; 12: 111–119.CrossRefGoogle ScholarPubMed
18.Gelder, Van, Sherwin, AL and Rasmussen, T. Amino acid content of epileptogenic human brain: focal versus surrounding regions. Brain Res 1972; 40: 385–393.CrossRefGoogle ScholarPubMed
19.Johnson, JW, Asher, P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 1987; 325: 529–531.CrossRefGoogle ScholarPubMed
20.Perry, TL, Hansen, S. Amino acid abnormalities in epileptogenic foci. Neurology 1981; 31: 872–876.CrossRefGoogle ScholarPubMed
21.During, MJ, Anderson, GM, Roth, RH, et al. A human dialytrode: in vivo measurements of neuroactive substances in the human hippocampus with simultaneous depth EEG recordings. Soc Neurosci Abstr 1989; 15: 140.8.Google Scholar
22.Sherwin, AL, Quesney, F, Gauthier, S, et al. Enzyme changes in actively spiking areas of human epileptic cerebral cortex. Neurology 1984; 34: 927–933.CrossRefGoogle ScholarPubMed
23.Kish, SJ, Dixon, LM, Sherwin, AL. Aspartic acid aminotransferase activity is increased in actively spiking compared with non-spiking human epileptic cortex. J Neurol Neurosurg Psychiatry 1988; 51: 552–556.CrossRefGoogle ScholarPubMed
24.Kish, SJ, Olivier, A, Dubeau, F , et al. Increased activity of choline acetyltransferase (ChAT) and cholinesterase (AchE) activity in spiking vs nonspiking human epileptic cortex. Epilepsy Res 1988; 2: 227–231.CrossRefGoogle Scholar
25.Koyama, I. Amino acids in the cobalt-induced epileptogenic and nonepileptogenic cat’s cortex. Can J Physiol Pharmacol 1972; 50: 740–752.CrossRefGoogle ScholarPubMed
26.Van Gelder, NM, Courtois, A.Close correlation between changing content of specific amino acids in epileptogenic cortex of cats and severity of epilepsy. Brain Res 1972; 43: 477–484.CrossRefGoogle ScholarPubMed
27.Reader, TA, Ferron, A, Decarries, L, et al. Modulatory role for bio-genic amines in the cerebral cortex. Brain Res 1979; 160: 217–229.CrossRefGoogle Scholar
28.Sherwin, AL, Dyve, S, Dubeau, F, et al. Postictal compensatory changes in cortical alpha-1 receptors and adrenergic-mediated phosphoinositol metabolism following repeated electroconvulsive seizures in rats. In: Avoli, M, Gloor, P, Kostopoulos, G, Naquet, R, eds. Generalized Epilepsy: Cellular, Molecular, Pharmacological Approaches. Boston: Birkhauser 1990; 407–422.CrossRefGoogle Scholar
29.Trottier, S, Lindvall, O, Chauvel, P, et al. Facilitation of focal cobalt-induced epilepsy after lesions of the noradrenergic locus coeruleus system. Brain Res 1988; 454: 308–314.CrossRefGoogle ScholarPubMed
30.Haycock, JW. Stimulation-dependent phosphorylation of tyrosine hydroxylase in rat corpus striatum. Brain Res Bull 1987; 19(6): 619–622.CrossRefGoogle ScholarPubMed
31.Neuman, RS. Suppression of penicillin-induced focal epileptiform activity by locus coeruleus stimulation: mediation by an alpha-1 adrenoreceptor. Epilepsia 1986; 27: 359–366.CrossRefGoogle Scholar
32.Gonzales, RA, Crews, FT, Sumners, C, et al. Norepinephrine regulation of alpha-1 receptors and alpha-1-stimulated phosphoinosi-tide hydrolysis in primary neuronal cultures. J Pharmacol Exp Ther l987; 242: 764–771.Google Scholar
33.Rosenbaum, JS, Azhar, S, Hoffman, BB. Alpha-1 adrenergic receptor mediated polyphosphoinositide breakdown in DDTi-MF2 cells. Biochem Pharmacol 1987; 36: 4335–4340.CrossRefGoogle ScholarPubMed
34.Nicoletti, F, Iadarola, MJ, Wroblewski, JT, et al. Excitatory amino acid recognition sites coupled with inositol phospholipid metabolism: developmental changes and interaction with alpha-1 adrenoceptors. Proc Natl Acad Sci U.S.A. 1986; 83: 1936–1935.CrossRefGoogle ScholarPubMed